Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy Versus Stereotactic Ablative Body Radiotherapy Alone for Spinal Metastases Invading the Spinal Canal: a Randomised, Non-inferiority Trial

NCT06613295 is registered in ClinicalTrials.gov with Cancer Research Antwerp as lead sponsor.

NCT NCT06613295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06613295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy Versus Stereotactic Ablative Body Radiotherapy Alone for Spinal Metastases Invading the Spinal Canal: a Randomised, Non-inferiority Trial
Lead sponsor
Cancer Research Antwerp
Phase
Not applicable
Overall status
Recruiting
Start date
March 7, 2022
Completion date
March 1, 2027
Enrollment
128 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, spinal neoplasms, spinal tumor